I would assume that this protocol submission must have been done in the Pre-IND…
“ we expect to be able to initiate our Phase 1 trial with 159 patients targeted based upon the FDA's approval of the protocol; they have it, we submitted that protocol to them.”
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links